Amgen

Avoiding, Treating & Curing Cancer With the Immune System | Dr. Alex Marson

Andrew Huberman

A large pharmaceutical company that is a leader in bispecific T-cell engagers ('bites'); uses AI to design synthetic proteins for cancer targeting.

A Conversation with Elizabeth Iorns - Advice for Biotech Founders

Y Combinator

A large pharmaceutical company that used Science Exchange for all of its discovery research, signifying product-market fit. Also mentioned for its successful migraine drug.

#35 – Nir Barzilai, M.D.: How to tame aging

Peter Attia MD

A biopharmaceutical company that developed an IGF receptor antibody for cancer treatment, which Dr. Barzilai's lab subsequently used in mouse longevity studies.

E129: Sam Altman plays chess with regulators, AI's "nuclear" potential, big pharma bundling & more

All-In Podcast

Company seeking to acquire Horizon Therapeutics; discussed in relation to FTC's antitrust concerns and its business strategy.

#24 – Tom Dayspring, M.D., FACP, FNLA – Part V of V: Lp(a), inflammation, oxLDL, remnants, and more

Peter Attia MD

A company that developed an EPA product (Vascepa/Vazita) and took the FDA to court to allow doctors to share data, leading to increased sales.

#23–Tom Dayspring Part IV of V: statins, Zetia, PCSK9 inhibitors, niacin, cholesterol & the brain

Peter Attia MD

A biotechnology company that developed Repatha, a PCSK9 inhibitor, which showed remarkable event reduction in the FOURIER trial.

Jim Collins — Good to Great — The Knowledge Project #67

The Knowledge Project Podcast

One of the very first biotechnology companies, founded in 1976. George Rathmann, its CEO, had an incredible sense of biotech's potential and defended its patents, eventually becoming a patient of its key product, EPO.

The Science of Hunger & Medications to Combat Obesity | Dr. Zachary Knight

Andrew Huberman

A pharmaceutical company developing an antibody-based dual GLP-1 and GIP inhibitor (AMG 133) for weight loss, which can be given monthly and shows long-lasting effects.

E32: Behind the scenes of Elon hosting SNL, CDC failures, America's real-time UBI experiment & more

All-In Podcast

Mentioned alongside Genentech for making proteins that became biologic drugs.

210 - Lp(a) and its impact on heart disease | Benoît Arsenault, Ph.D.& Peter Attia, M.D.

Peter Attia MD

A pharmaceutical company that produces PCSK9 inhibitors and is developing an siRNA compound (Olpasiran) against Lp(a).

346 - Scaling biotech and improving global health: lessons from an extraordinary career in medicine

Peter Attia MD

How To Build The Future: Parker Conrad

Y Combinator

A biotechnology firm where Parker Conrad worked after college in Los Angeles.